D-763
Nobiletin Determination by HPLC using UV-Vis Spectroscopy
Original Document
Scanned document (image-only PDF)
Extracted Text
Searchable text extracted from PDF
1.0 Purpose
The purpose of this procedure is to define the method for the quantitation and/or identification
of nobiletin in raw materials and finished product dietary supplements using HPLC and UV/VIS
spectrophotometry.
2.0 Scope
This procedure applies to the quantification and identification of nobiletin in raw materials and
finished products. Nobiletin is a good chromophore and was measured at 280, other wavelengths
can be used if interferences are present.
3.0 Responsibility
3.1 ‘It is the responsibility of QC and Analytical Chemists to follow this procedure.
3.2 It is the responsibility of QC Laboratory Management to ensure that this procedure is
being followed.
3.3. ‘It is the responsibility of QC Laboratory Management and/or Analytical Development to
keep this procedure aligned with current practices.
4.0 Definitions
4.1 UV/VIS — Ultraviolet and Visible Electromagnetic Spectrums
4.2 | KH2PO4— Monobasic Potassium Phosphate
4.3. | H3PQ4— Phosphoric Acid
4.4 ACN — Acetonitrile
4.5 HeO- Water (= 18.2MQ-cm, 0.22um filtered)
46 Nobiletin —2-(3,4-Dimethoxypheny]l)-5,6,7,8-tetramethoxychromen-4-one
4.7 QC-— Quality Control
[SOP
Standard Operating Procedure SOP No | Rev
Nobiletin Determination by HPLC using UV/VIS D-763 1 : ie
Spectroscopy i
5.0 References
5.1 USP41-NF36
DZ Analysis of Synephrine in the Peel of Citrus Fruit, Immature Citrus Fruit and Decoctions
of Chinese Medicinal Prescriptions Containing these Crude Drugs by Capillary
Electrophoresis
6.0 Supplies
6.1 Chemicals: All reagents are HPLC grade or better.
6.11 SEO
6.1.2 ACN
6.1.3 H3PQ,
6.1.4 KH2PO,
6.1.5 | Nobiletin reference standard
G.2 Glassware
6.2.1 HPLC vials, 12mm x 32mm with screw cap enclosures with septa
6.2.2 Scintillation Vials
6.2.3 Mobile Phase Containers
6.2.4 Volumetric glassware as required by standard and sample preparations
6.3 Disposables
6.3.1 10mL Pipette Tips
6.3.2 1mL Pipette Tips
6.3.3 200uL Pipette Tips
6.3.4 1.5mL centrifuge tubes
6.3.5 16mL Test Tubes
6.3.6 Disposable Plastic Luer Lock Syringe — 3mL, 6mL, or 10mL
6.3.7. Nylon Syringe Filters, 0.2um or 0.45pm
[SOP
Standard Operating Procedure SOP No | Rev
Nobiletin Determination by HPLC using UV/VIS D-763 | . oes
Spectroscopy .
6.3.8 Weigh paper
6.4 Equipment
6.4.1 Suitable gradient HPLC system consisting of a pump, autosampler, column oven
and UV detector with a chromatographic data handling system
6.4.2 Analytical Balance
6.4.3 Ultrasonic bath
6.4.4 Vortex
6.4.5 Stir Plate
6.4.6 Eppendorf Centrifuge
6.4.7. Adjustable Pipette(s)
7.0 Preparation of Mobile Phase, Diluent, Samples, and Standards
7.1 Mobile Phase A — Acetonitrile
1s Mobile Phase B — 0.5g/L of KH2POs (aq) adjusted to pH 3.5 with H3PO4
7.2.1. Prepared by adding 500mg KH2POs to a 1L volumetric flask and adding about
950mL H20. Adjust pH to 3.5 with H3PO4. After pH is adjusted, dilute to
volume with water.
7.3 Diluent—~ Mobile Phase A and Mobile Phase B (25:75)
7.4 Standard Preparation
7.4.1. Accurately weigh and transfer about 6.25 mg of reference standard into a 25-
mL volumetric flask.
7.4.2 Dissolve in and dilute to volume using Diluent.
7.4.3 Standard preparation may be scaled up if necessary.
7.5 Sample Preparation
7.5.1. Specific sample testing details are provided in each products profile. If a specific
testing details section is not available, then follow preparation procedure as
described below, maintaining concentration within the linear range listed below.
[SOP
Standard Operating Procedure SOP No | Rev
Nobiletin Determination by HPLC using UV/VIS D-763 I rie
Spectroscopy
7.5.1. For raw materials: weigh no less than 25 mg into a suitably sized volumetric
flask of no less than 25 mL. Dilute to volume using Diluent, and sonicate for 15
minutes.
fake: For solid dose finished products: Combine and homogenize no less than ten
dosage units. Based on the label claim and fill weight (for capsules) or tablet
weight per dose, weigh no less than 25 mg of the pooled dosages into a suitably
sized volumetric flask of no less than 25 mL, dilute to volume using Diluent,
and sonicate for 15 minutes.
Td. For liquid dose finished products: Use a TC pipet to transfer no less than 2.0 mL
of the product into a suitably sized volumetric flask of no less than 25 mL. Wipe
the outside of the pipet, and rinse the pipet three times with Diluent collecting
the rinses in the volumetric flask. Dilute to volume using Diluent.
7.5.4 For chewable gels (gummies), homogenize at least 10 dosage units according to
the procedure outlined in D-793 Cryogenic Grinding of Chewable Gels. Quickly
weigh a portion of the pooled and homogenized dosages into a glass beaker.
Dissolve the sample in Diluent, transfer the dissolved sample into a suitably
sized volumetric flask of no less than 25 mL volume using small portions of
Diluent to ensure complete transfer, and dilute to volume with Diluent.
7.5.5 Perform further dilutions as required using Diluent.
7.5.6 Filter an aliquot of the sample solution through a 0.45 um membrane discarding
the first 2 - 3 mL of filtrate before collecting a portion in a vial for analysis.
7.5.6.1 Alternatively, the solution may be centrifuged to remove particulates
provided that the final solution is clear.
8.0 Test Conditions
8.1 Gradient
Time YA %B
0.00 25 75
6.00 25 75
[SOP
Standard Operating Procedure SOP No | Rev
Nobiletin Determination by HPLC using UV/VIS D-763 | : tie
Spectroscopy
12.0 90 10
15.0 90 10
15.1 a3 75
18.0 25 75
8.2 Column — Phenomenex Luna, C18 (2), Sum, 100A, LC column, 150mm x 4.6mm, or
equivalent.
8.3 Flow Rate — 1.0mL/min
8.4 UV Detection — 280nm
8.5 Injection Volume — 10ynL
8.6 Column Temperature — 25°C
8.7 Recommended 3-D Spectral Range — 200nm to 400nm
8.8 Recommended Sequence
8.8.1 Make at least 2 injections of a Blank (Diluent).
8.8.2 Make five injections of the Working Standard.
8.8.3. Make a single injection of each Sample Preparation.
8.8.4 Makea single injection of the Working Standard after every ten samples and at
the end of the run.
8.9 System Suitability
89.1 The %RSD of five consecutive injections of the Working Standard is NMT
5.0%.
8.9.2 The %RSD of all standard injections is NMT 5%.
8.10 Recommended Column Wash and Storage
8.10.1 Rinse the column with H2O / ACN (90/10) at 1 mL/min for at least 15 min.
8.10.2 Rinse the column with H2O / ACN (50/50) at 1 mL/min for at least 10 min.
8.10.3 Store the column with H2O / ACN (50/50).
[SOP
Standard Operating Procedure SOP No | Rev
Nobiletin Determination by HPLC using UV/VIS D-763 1 Mey
Spectroscopy
9.0 Calculations
10.0 18-
16-
14>
12-
UAm
9.1 Example calculations for determining finished product % label or raw material % purity
R Wt aXP Vsnl SS
9.1.1 %9a ssay seen = —e x —SVetoa — x —saF xi—a x EON
Ry Sample peak area
Rg Mean standard peak area
Wtsiq Weight of reference standard in mg
Vista Volume of the standard preparation accounting for dilutions in mL
P Purity of the reference standard in decimal format
SA Sample amount in mg (solids) or mL (liquids)
Vspi Volume of the sample preparation accounting for dilutions in mL
SS Serving size: Weight of a single dosage unit in mg for tablets and
capsules, volume of a single serving from the theoretical formula in mL
for liquids, or 1 for raw materials.
LA Label amount in mg per dose or 1 for raw materials
Example Chromatography
&n
DO
&O
hcenroeameeL
netnaeemnneeeeeecL
10.1 Blank
Blank
ae)
S
S
D
os
1 2 3 4 5 6 7 8 9 10 11 #12 13 «14 #15 «160«©17~=«&W8
Time {min}
[SOP
Standard Operating Procedure SOP No | Rev
Nobiletin Determination by HPLC using UV/VIS D-763 , : oe
0
Spectroscopy
10.2. Working Standard
21AS089
800- 3 2=&
700-
Be
600-
500+
4 400-
300+
200+
co ts co
100+ | ges S
0 | ae x
3 4 5 6 7 8 9. 40 oT aa 48 ia es a i)
Time [min]
10.3 Sample
220457
S
300- iN
250-
a
5 2
<< — =
© 150-
1007
; = FILLE? 1
2 3 4 5 6 7 8 9 10 11 12 13 14 #15 #16 17~©«©18
Time {min]
11.0 Revision History
| Rev | Date | Description of Changes | CCR # | By |
|-----|----------|------------------------|-------|----|
| 0 | 01/02/19 | New N/A J. Maignan Update for consistency with current laboratory practices, simplify standard preparation, add specific sample prep instructions for 03/20/23 various dosage forms, add recommended sequence, add system CC-23-0144 S. Sassman suitability section, add column wash and storage recommendation, add example chromatography. Update logo and format. | - | - |